|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds|
|Kang-Ho Choi, Ja-Hae Kim, Changho Lee, Jae-Myung Kim, Kyung-Wook Kang, Joon-Tae Kim, Seong-Min Choi, Man-Seok Park, Ki-Hyun Cho|
J Stroke. 2021;23(2):273-276. Published online May 31, 2021
Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
Which is the Optimal Therapy to Prevent Thromboembolism After Atrial Fibrillation Ablation Procedures in Low Stroke Risk Patients, Anticoagulation or Antiplatelet Therapy?
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy: An ACTIVE W Substudy
Cerebral Microbleeds Are Uncommon in Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation
Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds
Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
Cerebral Microbleeds and Chronic Kidney Disease in Acute Ischemic Stroke Patients with Atrial Fibrillation
Periprocedural Management of Anticoagulation in Patients With Atrial Fibrillation
Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?
Prior antithrombotic therapy is associated with cerebral microbleeds but not leukoaraiosis in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease